Table: begin end state 1 22 cytoplasmic 23 50 transmembrane 51 62 non-cytoplasmic 63 83 transmembrane 84 90 cytoplasmic 91 110 transmembrane 111 115 non-cytoplasmic 116 137 transmembrane 138 149 cytoplasmic 150 170 transmembrane 171 178 non-cytoplasmic 179 198 transmembrane 199 257 cytoplasmic 258 281 transmembrane 282 296 non-cytoplasmic 297 318 transmembrane 319 328 cytoplasmic 329 348 transmembrane 349 359 non-cytoplasmic 360 383 transmembrane 384 395 cytoplasmic 396 422 transmembrane 423 427 non-cytoplasmic 428 446 transmembrane 447 472 cytoplasmic
Input: >16922 FitnessBrowser__Keio:16922 MVTINTESALTPRSLRDTRRMNMFVSVAAAVAGLLFGLDIGVIAGALPFITDHFVLTSRL QEWVVSSMMLGAAIGALFNGWLSFRLGRKYSLMAGAILFVLGSIGSAFATSVEMLIAARV VLGIAVGIASYTAPLYLSEMASENVRGKMISMYQLMVTLGIVLAFLSDTAFSYSGNWRAM LGVLALPAVLLIILVVFLPNSPRWLAEKGRHIEAEEVLRMLRDTSEKAREELNEIRESLK LKQGGWALFKINRNVRRAVFLGMLLQAMQQFTGMNIIMYYAPRIFKMAGFTTTEQQMIAT LVVGLTFMFATFIAVFTVDKAGRKPALKIGFSVMALGTLVLGYCLMQFDNGTASSGLSWL SVGMTMMCIAGYAMSAAPVVWILCSEIQPLKCRDFGITCSTTTNWVSNMIIGATFLTLLD SIGAAGTFWLYTALNIAFVGITFWLIPETKNVTLEHIERKLMAGEKLRNIGV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server